Article
Delivery of rapamycin-loaded nanoparticle down regulates ICAM-1 expression and maintains an immunosuppressive profile in human CD34+ progenitor-derived dendritic cells.
Journal of biomedical materials research. Part A - 15 Jun 2008
Das Saswati, Haddadi Azita, Veniamin Simona, Samuel John
Abstract excerpt
Immune responses of dendritic cells (DCs) can be modulated by delivery of adjuvants to alter their maturation profile. The purpose of this study was to generate DCs from CD34(+) cells of human cord blood and characterize the effects of poly(D,L-lactic-co-glycolic acid) (PLGA)-nanoparticle encapsu...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
